Posted by AGORACOM
at 2:22 PM on Tuesday, November 24th, 2020
Toronto, Ontario–(Newsfile Corp. – November 24, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“) today announces that its Annual and General Meeting of shareholders scheduled for Monday, November 30, 2020 will be held virtually due to the coronavirus (COVID-19) pandemic.
Due to the current COVID-19 lockdown in Toronto and in recognition of the latest directives and guidance from public health authorities and the Provincial and Federal Governments, this year’s meeting will be held virtually. The in-person meeting as described in the Company’s SEDAR filings and in its mailing to Shareholders will be happening online only. Shareholders will require a control number to be able to listen to, participate in and vote at the meeting in real time through the web-based platform of AGM Connect. The live audio webcast will be accessible at http://www.agmconnect.com/redlight2020 and will be held on Monday, November 30, 2020 at 11:00am EST.
IMPORTANT DETAILS FOR REGISTERED SHAREHOLDERS
Registered Shareholders who wish to attend the meeting and vote at the meeting, must register no later than 10:00am EST on Monday, November 30, 2020 at https://www.agmconnect.com/redlight2020. They must provide the shareholder name (as it is registered with the Company’s transfer agent), an email address for contact and the Proxy Control Number found on the Proxy Form or the Voter Information Form received by mail from TSX Trust or other intermediaries as the case may be. Registered Shareholders will then receive voting credentials for the Annual Meeting directly from AGM Connect.
All Shareholders are encouraged to vote in advance by one of the methods described in the 2019 Management Information Circular. Registered shareholders are asked to return their completed proxies or exercise their vote by the voting deadline on Thursday, November 26, 2020 at 11:00am EST.
If you have any questions, please call our transfer agent, TMX Trust via phone or online:
+1 416 361-0930 Toll-free North America: +1 866 393-4891
https://www.voteproxyonline.com
About Red Light Holland Corp.
The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM
at 12:07 PM on Tuesday, November 24th, 2020
sponsor: Durango owns 100% interest in the Trove claims, in the Windfall Lake area between Val d’Or and Chibougamau, Quebec., which are surrounded by Osisko Mining Inc. The property is compelling due to the coincidence of gold found in tills, coinciding with magnetic highs, several Induced Polarization anomalies and two faults crosscutting the property. Durango is undergoing a final review process for the proposed 3,000m drill program in 2020. Click Here For More Info
Crescat November Research Letter:
Gold & Silver Miners Turn Over a New Leaf:
Top 50 largest gold and silver miners have had five straight quarters of positive free cash flow for the first time in the last three decades.
Gold and silver mining companies are the real beneficiaries of today’s macro environment with strong balance sheets, high growth, and still incredible undervaluation.
One of the few areas of the equity market that is meaningfully improving fundamentally is the precious metals mining industry. With gold and silver prices at their current levels, these companies are set to massively expand their margins. This is indeed a new phenomenon for the miners. After 25 years of constantly losing money and regrettably creating a long-standing reputation of being capital destroyers, this industry is becoming one of the most disciplined and profitable businesses in the global economy today. In fact, the median stock among top 50 largest gold and silver miners has had five straight quarters of positive free cash flow for the first time in the last three decades. We believe this is only the beginning. These stocks are becoming new cash flow machines with the strong support of precious metals prices moving higher. Gold and silver mining companies are the real beneficiaries of today’s macro environment with strong balance sheets, high growth, and still incredible undervaluation.
Risk Parity Exhaustion
Among all the demand drivers for gold, we view the lack of competing cheap assets being a major one. For the first time in history, junk bonds and stocks are record overvalued in tandem. We have only seen the exact opposite of this. That was in the Global Financial Crisis when US equities and corporate bonds both hit rock bottom. This time, we are on the other side of the coin. Both sides of the so-called risk parity strategy, stocks and bonds, are at extreme valuations. In a world of near zero to negative yields and frothy valuations across almost every risky asset, it will become imperative for investors to seek out undervalued assets that are true beneficiaries of the current macro environment. In our view, precious metals are poised to become the new core must-have asset for capital allocators. Gold and silver are risk-off alternatives to bonds in the portfolios of prudently minded investors in today’s market. At the same time, attractively priced, high-growth gold and silver mining companies serve to ignite the animal spirits of traders and investors looking for a risk-on alternative to overvalued, low-growth stocks at large.
Posted by AGORACOM
at 10:53 AM on Tuesday, November 24th, 2020
SPONSOR: Thoughtful Brands is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Thoughtful is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe
“You are driving in your car on a very stormy day. You drive by a bus stop and see 3 people waiting there. The first is a beautiful woman, the perfect woman of your dreams.
The second is an old friend who once saved your life.
The third is a lonely old lady who looks really sick.
You have room for only one passenger. To whom would you offer a ride?”
This was a moral and ethical dilemma actually used by Steve Jobs, co-founder of Apple, as part of a job interview.
Do you pick up the old lady because she seems to need medical attention and you should try and help her?
Do you pick up the old friend because he once saved your life and this is the perfect opportunity to repay him?
However, both those choices leave you missing out on the woman of your dreams.
The candidate hired, out of 30 applicants, however, had no trouble answering. He simply said, “I would give the car keys to my old friend, let him drive the old lady to the hospital, and stay behind to wait for the bus with the woman of my dreams.”
His answer surprised even Jobs.
“Everyone is born with an instinct for success but only those with the ability to think outside the box succeed.”
Steve Jobs credited his outside-the-box perspective to LSD. He felt it had made him think of the world in a different way. He said, “Taking LSD was a profound experience, one of the most important things in my life.” Jobs never failed to ask job applicants whether they had ever used psychedelics.
Francis Crick, of the DNA-structure discovering Watson and Crick, told numerous friends and colleagues about his LSD experimentation during the time he spent working to determine the molecular structure of DNA that houses all life’s information. The Cambridge University’s researchers often used LSD as “a thinking tool.” Crick actually “perceived the double-helix shape of DNA while on LSD.”
John Lennon: “It was such a mammoth experience that it was unexplainable: It was something that had to be experienced, because you could spend the rest of your life trying to explain what it made you feel and think.”
Ken Kesey wrote “One Flew Over the Cuckoo’s Nest” in 1962. He leveraged his position as a thought leader to popularize LSD use. “I believe that with the advent of acid, we discovered a new way to think, and it has to do with piecing together new thoughts in your mind.”
Kary Mullis is a Nobel prize winning biochemist who invented the polymerase chain reaction (PCR) technique. This technique is used to make copies of DNA segments and is standard in criminal forensics, diagnosing diseases (including the current test for Coronavirus), and in genetic research. A year after winning the Nobel prize, the scientist said his LSD use in the 60’s and 70’s was far more important to his accomplishments than any courses he ever took in school. Not only that, he claims his entire legacy probably depended on using LSD. “What if I had not taken LSD ever; would I have still invented PCR? I don’t know. I doubt it. I seriously doubt it.”
Frances McDormand – Most people know McDormand as the plucky sheriff from the cult movie Fargo, but she “really, really enjoyed LSD.” The actress says that the drug is a deeply profound experience, and hopes that one day the government can “figure out this whole legalization thing.”
Ray Charles – LSD was most definitely on his mind. “LSD made the blind man see.”
Jean-Paul Sartre, the French existentialist philosopher, playwright, novelist, screenwriter, political activist, biographer, and literary critic, one of the leading figures in 20th century French philosophy and a key proponent of Existentialism, experimented regularly with mescaline.
Sam Harris is an American author, neuroscientist, and philosopher: “I have two daughters who will one day take drugs. If they don’t try a psychedelic like psilocybin or LSD at least once in their adult lives, I will wonder whether they had missed one of the most important rites of passage a human being can experience.” “There was a period in my early twenties when I found psilocybin and LSD to be indispensable tools, and some of the most important hours of my life were spent under their influence. Without them, I might never have discovered that there was an inner landscape of mind worth exploring.” “The positive experiences were far more sublime than I could ever have imagined or than I can now faithfully recall. These chemicals disclose layers of beauty that art is powerless to capture. Positive psychedelic experiences reveal how wondrously at ease in the universe a human being can be – and for most of us, normal waking consciousness does not offer so much as a glimmer of those deeper possibilities.”
A rapidly growing number of young professionals in Silicon Valley and elsewhere insist that taking small doses of psychedelic drugs simply makes them perform better at work – becoming more creative and focused. The practice, known as “microdosing”, involves taking minute quantities of drugs such as LSD, psilocybin (magic mushrooms) or mescaline (peyote cactus).
Silicon Valley also has a long history of psychedelic drug use to boost creativity: technology stars Steve Jobs and Bill Gates both famously experimented with LSD.
At high doses, LSD powerfully alters perception, mood and a host of cognitive processes. LSD now appears to be one of the more commonly microdosed drugs. A microdose of LSD consists of about a tenth of a recreational dose (usually 10-20 micrograms), which is not potent enough to cause any hallucinations. Instead, it is reported to heighten alertness, focus, energy and creativity.
Joe Rogan, the host of one of the most listened-to podcasts and another California resident, is a big proponent of micro-dosing mushrooms and has had numerous guests on his shows, ranging from scientists to executives to artists and writers to athletes and MMA fighters, who have shared their positive experiences from micro-dosing.
Studies have been done on the therapeutic effects of psilocybin for terminally ill cancer patients at Johns Hopkins, who were crippled by crushing, overwhelming anxiety about their impending death.
“For a few hours, I remember feeling at ease; I was simultaneously comfortable, curious and alert. More than anything, though, I no longer felt alone. The whole “self” thing just kind of drops out into a more timeless, more formless presence, the crushing anxiety lifted,” one patient said.
Aldous Huxley, Timothy Leary and Steve Jobs all used psychedelic drugs when they died.
In a landmark decision in August, 2020, four Canadians suffering from terminal illnesses were approved by Health Canada to receive Psilocybin therapy to treat their anxiety – marking the first time that a legal exemption has been given in Canada for patients to access psychedelic substances for treatment.
One of the four spoke to CTV News in June about his struggle with terminal cancer, and the crushing fear that such a diagnosis brings.
The 52-year-old’s anxiety about the end of his life was making his current days unbearable, and anti-anxiety medication wasn’t having the effect he needed.
It was this suffering that pushed him and three other Canadians with similar diagnoses towards Psilocybin.
Research tracking the effects of the psychedelic drug has found that it has the potential to provide long-term relief for mental health struggles such as anxiety and depression, especially in those receiving palliative care due to a terminal diagnosis.
The U.S. Center for Psychedelic and Consciousness at Johns Hopkins University in Baltimore is currently running clinical trials to assess whether the drug should be released on the market as a prescription medication.
In the 2020 US presidential elections, the state of Oregon voted in a proposition to legalize Psilocybin for mental health treatment and to decriminalize the possession of small amounts of all drugs for personal use. The new law will come into effect on 1 February 2021. On the same day Washington, D.C. passed an initiative to decriminalize the cultivation and possession of “entheogenic plants and fungi (magic mushrooms containing psilocybin).
Kevin O’Leary, “Mr Wonderful” on the TV show Shark Tank, is backing MindMed, a neuro-pharmaceutical company testing psychedelic-inspired medicines.
O’Leary cited the potential of its drugs to address problems like depression, alcoholism, and opioid addiction, issues that haven’t seen medical innovations in almost three decades.
Mind Medicine (MindMed) Inc. is a public company seeking to apply psychedelics to societal problems including anxiety, depression, PTSD, ADHD, cluster headaches and addiction.
The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The Company has a number of trials underway, including a trial that seeks to understand whether combined dosing of MDMA and LSD could mitigate bad trips, studies into Psilocybin and studies on the use of microdoses of psychedelics for cognitive enhancement.
We are living through a seismic shift in social and legal attitudes toward….. just about everything, from gender and sexuality to mental and physical healthcare to race and class.
Now it’s time to look ahead to the next major investment trend to come out of the drug reform movement: psychedelic medicine.
Psychedelic medicine is coming back. A recent study from the Johns Hopkins University School of Medicine shows Psilocybin is an effective addiction treatment. And investors around the world are starting to take notice.
Posted by AGORACOM
at 8:27 AM on Tuesday, November 24th, 2020
Graphite Exploration Companies in North American Garnering Attention from Investors
Vancouver, B.C., Nov. 24, 2020 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) is focused on the exploration and development of flake graphite in Quebec for the new green economy. Lomiko is pleased to announce the Lomiko Technical, Safety and Sustainability Committee (“LTSSC”) has recommended the acceptance of a Proposal by SGS Canada Inc. to conduct a Metallurgical Process Development Program to the Board of Directors. This Program has been accepted and approved by the Lomiko Board.
SGS Metallurgical Process Development Plan
Lomiko plans to ship four composites weighing 30 – 35 kg each consisting of high-grade and low-grade samples from the Refractory and the Graphene Battery mineralized zones will be shipped to SGS in Lakefield. The main scope of the work program includes:
Sample Preparation
Chemical Characterisation
Comminution Testing
Flowsheet Development
Environmental Testing
The samples will be stage-crushed in a series of jaw and cone crushers to minimize the risk of flake degradation and fines generation. Samples will be extracted for comminution testing, chemical characterization, and the generation of two Master composites.
Bond ball mill grindability tests will be carried out to establish grinding energy requirements to assist in the design of the preliminary comminution circuit.
Scoping level flowsheet development testing will be carried out on the two Master composites to establish a conceptual flowsheet. The primary objectives of the flowsheet development program are to maximize the graphite recovery into a flotation concentrate while minimizing flake degradation. The final concentrates will be subjected to size fraction analyses to determine the flake size distribution and total carbon grade profile of the two mineralized zones.
The high-grade and low-grade samples of the two mineralized zones will be subjected to variability flotation testing using the flowsheet and conditions that were developed for the two Master composites. Since a flowsheet must be able to treat all domains encountered in a deposit, these variability tests serve the purpose of assessing the robustness of the proposed flowsheet.
Static geochemical tests will be carried out to assess the acid-generating potential of the La Loutre tailings with and without a sulphide rejection circuit.
Lomiko’s Near Term Goals
Graphite demand is expected to increase exponentially for the mined natural graphite material, as more is used in the production of spherical graphite for graphite in the anode portion of Electric Vehicle Lithium-ion batteries.
Lomiko completed a $ 750,000 financing October 23, 2020 and plans to work on its near-term goals:
1) Complete 100% Acquisition of the Property, currently 80% owned by Lomiko Metals.
2) Complete metallurgy and graphite characterization to confirm li-ion anode grade material.
3) Complete a Technical Report to confirm that the extent of the mineralization equals or surpasses the nearby Imerys Mine, owned by international mining conglomerate.
A “technical report” means a report prepared and filed in accordance with this Instrument and Form 43-101F1 Technical Report, and includes, in summary form, all material scientific and technical information in respect of the subject property as of the effective date of the technical report;
4) Complete Preliminary Economic Assessment (PEA)
A PEA means a study, other than a pre-feasibility or feasibility study, that includes an economic analysis of the potential viability of mineral resources.
Posted by AGORACOM
at 5:38 PM on Monday, November 23rd, 2020
Gold & Silver Miners Turn Over a New Leaf:
Top 50 largest gold and silver miners have had five straight quarters of positive free cash flow for the first time in the last three decades.
Gold and silver mining companies are the real beneficiaries of today’s macro environment with strong balance sheets, high growth, and still incredible undervaluation.
One of the few areas of the equity market that is meaningfully improving fundamentally is the precious metals mining industry. With gold and silver prices at their current levels, these companies are set to massively expand their margins. This is indeed a new phenomenon for the miners. After 25 years of constantly losing money and regrettably creating a long-standing reputation of being capital destroyers, this industry is becoming one of the most disciplined and profitable businesses in the global economy today. In fact, the median stock among top 50 largest gold and silver miners has had five straight quarters of positive free cash flow for the first time in the last three decades. We believe this is only the beginning. These stocks are becoming new cash flow machines with the strong support of precious metals prices moving higher. Gold and silver mining companies are the real beneficiaries of today’s macro environment with strong balance sheets, high growth, and still incredible undervaluation.
Risk Parity Exhaustion
Among all the demand drivers for gold, we view the lack of competing cheap assets being a major one. For the first time in history, junk bonds and stocks are record overvalued in tandem. We have only seen the exact opposite of this. That was in the Global Financial Crisis when US equities and corporate bonds both hit rock bottom. This time, we are on the other side of the coin. Both sides of the so-called risk parity strategy, stocks and bonds, are at extreme valuations. In a world of near zero to negative yields and frothy valuations across almost every risky asset, it will become imperative for investors to seek out undervalued assets that are true beneficiaries of the current macro environment. In our view, precious metals are poised to become the new core must-have asset for capital allocators. Gold and silver are risk-off alternatives to bonds in the portfolios of prudently minded investors in today’s market. At the same time, attractively priced, high-growth gold and silver mining companies serve to ignite the animal spirits of traders and investors looking for a risk-on alternative to overvalued, low-growth stocks at large.
Posted by AGORACOM
at 4:12 PM on Monday, November 23rd, 2020
Gratomic recently made 2 announcements accelerating the Aukam Mine toward commercial production.
Retained 100% of the rights and interests in the Aukam Mining and Exploration License
Final Phase of construction on Aukam Processing Plant set to begin
Gratomic will optimize the potential of the Aukam graphite mine through it’s 100% ownership and the accelerated development of the building process. The final phase of foundation construction for the Rotary Drier, Filter Press, Cyclone, Material Hopper, Material Thickener Tank and Product Thickener Tank is currently in process and sets up the final build out for the Aukam Mine and production. Gratomic is focused on low-cost mine to market commercialization of carbon-neutral, Eco-friendly, high purity vein graphit. These critical steps allow Gratomic to become a key player in EV and Renewable Resource supply chains.
Aukam Graphite is high purity graphite and ideal for North American battery grade standards for use in Li-ion battery anodes.
Retaining 100% ownership and advancing Aukam toward commercial production are key steps toward becoming a leader in the emerging EV Market.
Watch the Evolution of the Aukam Mine:
https://youtu.be/cYvaL4aVF7Q
FULL DISCLOSURE: Gratomic is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM
at 3:34 PM on Monday, November 23rd, 2020
American Creek Resources (AMK:TSX-V) Treaty Creek Project has been the subject of incredible discussion in 2020, including by Eric Sprott who stated Treaty Creek may have as much as 50,000,000 ounces of gold this summer.
There isn’t a single junior exploration company that isn’t envious of Treaty Creek and the one good problem it is creating for the Company – it is overshadowing everything else in the Company. As such, AMK recently announced the following:
“American Creek Announces Spinout of Dunwell Property and Other Properties and Assets and Sets Date for Annual General & Special Meeting”
Watch this powerful interview with CEO Darren Blaney as to the reasons for the spinout that go well beyond the obvious.
Posted by AGORACOM-JC
at 2:58 PM on Monday, November 23rd, 2020
https://youtu.be/CBP9fkwiaV0
Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has provided an update on their Injectable CBD delivery system that allows control release.
Bincovich telling Proactive some of the recent works done to prove the efficacy of the project and also a bit of detail of the man leading the project, Prof Chezy Barenholz from the Hebrew University.
Posted by AGORACOM-JC
at 11:10 AM on Monday, November 23rd, 2020
Despite the collapse of marijuana and cannabis related stocks in the last 18 months, there is no denying that Cannabis related products are going to go through a paradigm shifting, parabolic growth stage around the world over this decade for the following reasons:
1. Cannabis legalization is gaining momentum around the world.
2. Momentum is primarily driven by the realization that cannabis may have a range of medicinal, therapeutic and wellness applications.
3. It is the most widely cultivated, consumed and trafficked drug worldwide (United Nations Office on Drugs and Crime).
So what is this going to translate into?
The global cannabis market size was valued at $US 10.6 Billion in 2018 and is projected to reach $97.5 Billion by the end of 2026, a CAGR of 32.92%(Fortune Business Insights)
WHY WILL THIS TIME BE DIFFERENT?
Big promises, big IR budgets, big hype …. Big Letdown.
That pretty much sums up the last cycle of Cannabis related companies that focused on speed, stories and stock prices rather than the one simple but important thing they should have been doing – building a real business.
Investors will remember that the same thing happened during the dot-com era. As with the cannabis collapse over the last 18 months, what followed back in 2000 was a long period of mourning in which many investors had sworn off tech stocks, just as they have with cannabis stocks today.
But it wasn’t long until tech investors dusted themselves off and realized tech was here to stay – but this time they were only going to focus on real companies with real businesses. What we got was Amazon, Google, Linkedin, Facebook and then the rest was history.
US LEGALIZATION IS ACCELERATING
After postponing a proposed September vote, the full U.S. House of Representatives is expected to vote in December on a bill that would effectively legalize marijuana federally by removing it from the Controlled Substances Act.
According to Politico, the House Democratic leadership is preparing for a vote on the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019. In addition to legalizing marijuana federally, the legislation would allow states to continue to choose how to regulate a commercial MJ industry.
Democrats in close elections balked at voting on the MORE Act in September amid concerns that voters might question the importance of legalizing marijuana when Congress had failed to agree on a coronavirus aid package.
But in the November election, five more states legalized medical and/or recreational marijuana, and a recent poll shows cannabis legalization is more popular than ever.
Big cap marijuana stocks have already seen significant gains
Meet the 8 new small cap marijuana horsemen of the next leadership group that are firing on all cylinders (in alphabetical order).
Avicanna (AVCN :TSX) (AVCN : OTCQX) ( 0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:
1. The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year. These are the only known CBD cosmetics backed by clinical trials.
2. Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia.
3. Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.
For more information about the company, please check out the Avicanna HUB on AGORACOM.
Harborside (HBOR: CSE), (HSDEF: OTCQX) has generated over $400,000,000 (NOT a typo) since its inception in 2006. We thought that would get your attention.
What Do They Do?
HBOR is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments:
1. Retail Dispensaries
2. Wholesale
3. Cultivation and Processing
HIGHLIGHTS
Founded in 2006. One of the oldest and most respected cannabis retailers in California
Awarded one of the first six medical cannabis licenses in the USA
Operations have generated over $400M in cumulative sales since inception
Retail operations command 3% of California’s entire retail market
Q3 REVENUE ($USD)
· $19.6M +43% vs. Q3 2019
9 MONTHS ENDED SEPT. 30, 2020
· $50.4M + 33% vs 2019
OTHER Q3 HIGHLIGHTS
21.2% Sequential Revenue Growth, with Record Gross Revenues and Continued Positive Adjusted EBITDA of $4.5 million
Strong Combined Gross Margin of 54.7% (1) Driven by Improved Harvest Yields and Higher Wholesale Volumes
Expects Full Year Gross Revenues of Approximately $61 Million – $63 Million with Adjusted EBITDA of 8-10%
For more information about the company, please check out the Harborside Inc hub on AGORACOM.
Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success:
REVENUES $USD
Q1 +317% YoY to $862,000
Q2 +3685% YoY to $8,500,000
Q3 +5081% YoY to $12,500,000
TOTAL Q1/Q2/Q3
REVENUE $21.8M
With the recent passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona Hollister is extremely well positioned to capitalize. This can best be summed up by quote of Venom Extracts Founder below:
“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona
On September 23rd, 2020, Venom achieved the first revenue milestone by generating in excess of CDN$30,000,000 of revenue calculated from January 1 st , 2020
In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:
For more information about the company, please check out the Hollister Biosciences Inc. hub on AGORACOM.
Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.
3 Fully Operating Divisions For Investor Diversification
Innocan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.
Global Manufacturing / Distribution Agreements
Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
Superior Management Team
In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself. The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:
Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
Together they have built one of the most formidable teams in the small cap cannabis world
For more information about the company, please check out the Innocan Pharma Corporation hub on AGORACOM.
Spyder Cannabis Inc. (SPDR :TSXV) is a Cannabis, Vape and CBD retailer with three retail business units.
SALE OF CANNABIS PRODUCTS – The Company has TWO cannabis dispensaries currently in operation. The first being a location in Calgary, Alberta and the second in Niagara Falls. Both dispensaries are located in busy commercial hubs. The management team is currently evaluating several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.
SALE OF HEMP CBD (US) Company is also pursuing the sale of Hemp based CBD products from locations in the USA.
SMOKING CESSATION PRODUCTS IN ONTARIO The company sells electronic cigarettes, E-juice and accessories for the “vape” business from five Canadian retail locations; Woodbridge, Scarborough, Pickering, Niagara Falls and Burlington, Ontario. Spyder has established itself as a savvy retailer.
For more information about the company, please check out the Spyder Cannabis hub on AGORACOM.
Thoughtful Brands, Inc. (TBI: CSE)( 1WZ1: FWB)( PEMTF: OTCQB) is a global natural health products and eCommerce technology company that is operating at full throttle.
Acquired eCommerce retailers with combined total sales of approximately $29,000,000 with an EBITDA of approximately 12.5%.
Current customer base of over 200,000 customers with additional leads of over 600,000 potential new customers
Enhanced eCommernce solution through Unified Funding’s software which facilitated over $350 million in consumer transactions (CAD $93.8 million) in 2019 from more than one million paying customers.
Low-cost production will be vertically integrated into retail brands to achieve up to 20x margin increase.
We’ll let these revenue numbers speak for themselves.
August 2020 CAD $3,809,000
July 2020 CAD $2,340,000
June 2020 CAD $2,712,000
The above represents an increase of 19%, over the same period in 2019.
QUARTERLY REVENUE $CAD
Q1 $7,600,000 Growth
Q2 $12,800,000 Growth
TOTAL Q1 AND Q2
REVENUE $20,400,000
GROSS PROFIT $2,154,357
The company has its sights set on European expansion through a joint venture with Franchise Cannabis Corp. The company will now sell and market Franchise-manufactured CBD, hemp and cosmetic products in the European Union, Switzerland, Norway and the UK, utilizing its eCommerce platform.
The company also completed acquisition of Verrian, which owns and operates a 110,000-square foot pharmaceutical manufacturing facility in Radebuel, Germany. This acquisition will assist the company in tapping into the burgeoning market for psychedelics as Verrian specializes in developing psychedelic derived medicines for treatments for addictions, including opioids and alcohol.
In Addition, the company entered into a definitive agreement to acquire American CBD Extraction Corp. and its Kentucky-based wholly owned subsidiary East Kentucky Extractions, LLC. the Company will gain access to an abundance of hemp biomass in Kentucky, and own a fully equipped and licensed 41,000 square foot facility that can process more than 1,200 pounds of hemp per day.
For more information about the company, please check out the Thoughtful Brands hub on AGORACOM.
TransCanna (TCAN:CSE) (TH8:FSE) owns a 196,000 square foot cannabis Facility, the largest known fully licensed cannabis facility in California.
CAD$24.9M Revenue Run Rate from 10,000 sq.ft test facility
CAD $90M Annual Revenue expected from first full year of production at Fully Licensed Daly Street Facility.
Acquired two California companies,
High-end award winning edible producer Soldaze
Premium indoor cultivator and distributer Lyfted Farms
Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
2019 California Cannabis sales over $3B, industry currently fragmented
Direct to dispensary model, cutting out the middleman
REVENUES $CAD
Q1 $906,000
Q2 $4,300,000
TOTAL Q1 AND Q2
REVENUE $5,206,000
GROSS MARGIN $1,920,000
OFF-TAKE AGREEMENTS
· The Company has secured multiple off-take agreements in anticipation of late Q1 production coming out of the Daly facility
REVENUE GUIDENCE
· Company’s internal gross revenue target for the 2020 fiscal year ranges from CAD$12,000,000 up to CAD$14,000,000 (with anticipated net profits from sales of $600,000 up to $700,000) On track to achieve this benchmark
Company maintains its guidance for a gross revenue target of CAD$55,000,000 to CAD$75,000,000 (with anticipated net profits from sales of $6,600,000 up to $9,000,000) for the fiscal year 2021.
This revenue guidance is only for phase one of four in the Daly facility
· For more information about the company, please check out the TransCanna hub on AGORACOM.
Thanks for reading and discovering these great small cap cannabis companies. Please be sure to visit the AGORACOM Small Cap Cannabis Gateway often to stay up to date with new companies at:
Posted by AGORACOM-JC
at 10:31 AM on Monday, November 23rd, 2020
Following the release of its Third (3rd) Quarter Financial Results on Thursday, November 26 at market close, the Company’s CEO Johnson Joseph and CFO Jean Landreville will host a webinar to discuss the highlights of the quarter followed by a Q&A period.
Those interested can click the following link to register to attend the webinar on Thursday, November 26 at 4:30 PM EST: https://bit.ly/395OGxl
Montreal, Quebec–(November 23, 2020) – Peak Positioning Technologies Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that, following the release of its Third (3rd) Quarter Financial Results on Thursday, November 26 at market close, the Company’s CEO Johnson Joseph and CFO Jean Landreville will host a webinar to discuss the highlights of the quarter followed by a Q&A period.
Those interested can click the following link to register to attend the webinar on Thursday, November 26 at 4:30 PM EST: https://bit.ly/395OGxl
While there will be an opportunity to ask questions at the end of the presentation, Peak encourages its shareholders to send questions in advance to CHF Capital Markets at [email protected]. Should the Company not answer your question during the webinar, CHF will follow-up with a response after the event is over.
Peak management is looking forward to seeing you at the webinar.
About Peak Positioning Technologies Inc.:
Peak Positioning Technologies Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating in China’s commercial lending industry. Peak’s subsidiaries use technology, analytics and artificial intelligence to create an ecosystem of lenders, borrowers and other participants in China’s commercial lending space where lending operations are conducted rapidly, safely, efficiently and with the utmost transparency. For more information: http://www.peakpositioning.com.
For more information, please contact:
CHF Capital Markets Cathy Hume, CEO 416-868-1079 ext.: 251 [email protected]
Peak Positioning Technologies Inc. Johnson Joseph, President and CEO 514-340-7775 ext.: 501 [email protected]
This news release may include certain forward-looking information, including statements relating to business and operating strategies, plans and prospects for revenue growth, using words including “anticipate”, “believe”, “could”, “expect”, “intend”, “may”, “plan”, “potential”, “project”, “seek”, “should”, “will”, “would” and similar expressions, which are intended to identify a number of these forward-looking statements. Forward-looking information reflects current views with respect to current events and is not a guarantee of future performance and is subject to risks, uncertainties and assumptions. The Company undertakes no obligation to publicly update or review any forward-looking information contained in this news release, except as may be required by applicable laws, rules and regulations. Readers are urged to consider these factors carefully in evaluating any forward-looking information.
